Evaluation of BAL Procedure With Ambu aScope 3 Large in Patients in an ICU Setting

NCT ID: NCT03581474

Last Updated: 2020-02-13

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-09-28

Study Completion Date

2018-07-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

An Investigation to determine the single-use scope's ability to suction secretion from the lungs to resolve the collapse of the lung.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this investigation it to determine the single-use scope's ability to suction secretion from the lungs to resolve the collapse of the lung. The hypothesis is that aScope 3 Large is able to manage the secretion and thereby facilitating the resolution of secretion in the lung.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atelectasis Bronchoscopy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

aScope 3 Large

Bronchoscopic procedure

Group Type OTHER

Bronchoscopic procedure

Intervention Type DEVICE

Single-use flexible bronchoscope aScope 3 Large

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bronchoscopic procedure

Single-use flexible bronchoscope aScope 3 Large

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients ≥18 years
* Clinical indication and eligible for a BAL procedure, as judged by the investigator
* Patients being admitted in the ICU at the investigational centre
* Provision of signed IC by subject, or subject's legal representative e.g. next of kin

Exclusion Criteria

* Patients where BAL treatment cannot be clinically justified, judged by the investigator
* ETT \>7 mm and ≤8.5 mm in diameter
* Participating in other interventional clinical investigations or have previously participated in this investigation
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ambu A/S

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Anna Charlotte Lundgaard

Role: STUDY_CHAIR

Ambu A/S

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Chicago Medicine

Chicago, Illinois, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CIS-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Tracheobronchial Secretion Removal
NCT00932776 COMPLETED NA
Pressure Levels on Lung Expansion
NCT03027180 COMPLETED NA